Androgen Receptor Signaling Inhibitors in Nonmetastatic Castration-resistant Prostate Cancer and Risk of Cardiovascular Toxicity: All That Glitters Isn't Gold

被引：2
|
作者：
Di Lorenzo, Giuseppe [1 ,2 ]
Autorino, Riccardo [3 ]
机构：
[1] ASL Salerno, Oncol Unit, Andrea Tortora Hosp, I-84016 Pagani, Italy
[2] Univ Molise, Vincenzo Tiberio Dept Med & Hlth Sci, Campobasso, Italy
[3] VCU Hlth, Massey Canc Ctr, Urol Oncol, Richmond, VA USA
来源：
EUROPEAN UROLOGY | 2020年 / 78卷 / 05期
关键词：
TRIAL;
D O I：
10.1016/j.eururo.2020.07.036
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：647 / 649
页数：3
相关论文
共 50 条
  • [1] Androgen Receptor Inhibitors in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
    George, Daniel J.
    Morgans, Alicia K.
    Constantinovici, Niculae
    Khan, Nasreen
    Khan, Javeed
    Chen, Guifang
    Hlebec, Vlasta
    Shore, Neal D.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [2] Safety differences across androgen receptor inhibitors in nonmetastatic castration-resistant prostate cancer
    Shore, Neal
    Garcia-Horton, Viviana
    Terasawa, Emi
    Ayyagari, Rajeev
    Grossman, Jamie Partridge
    Waldeck, Adrianus Reginald
    FUTURE ONCOLOGY, 2023, 19 (05) : 385 - 395
  • [3] Clinical Outcomes and Prognostic Factors in Nonmetastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Signaling Inhibitors Therapy
    Fujiwara, Ryo
    Yamamoto, Shinya
    Takemura, Kosuke
    Yuasa, Takeshi
    Numao, Noboru
    Oguchi, Tomohiko
    Yasuda, Yosuke
    Yoneoka, Yusuke
    Yonese, Junji
    CANCERS, 2024, 16 (15)
  • [4] Factors That Guide Selection Among Androgen Receptor Inhibitors in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
    Rettig, Matthew B.
    Beltran, Himisha
    Oh, William K.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 1 - 19
  • [5] Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
    Feng, Qin
    He, Bin
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [6] Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors
    Saad, Fred
    Boegemann, Martin
    Suzuki, Kazuhiro
    Shore, Neal
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (02) : 323 - 334
  • [7] Novel androgen receptor inhibitors in nonmetastatic castration-resistant prostate cancer: A network meta-analysis
    Hird, Amanda Elizabeth
    Magee, Diana E.
    Bhindi, Bimal
    Ye, Xiang Y.
    Chandrasekar, Thenappan
    Goldberg, Hanan
    Klotz, Laurence
    Fleshner, Neil
    Satkunasivam, Raj
    Klaassen, Zachary William Abraham
    Wallis, Christopher J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [8] Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors
    Fred Saad
    Martin Bögemann
    Kazuhiro Suzuki
    Neal Shore
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 323 - 334
  • [9] Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer
    Aragon-Ching, Jeanny B.
    ASIAN JOURNAL OF ANDROLOGY, 2020, 22 (01) : 76 - 78
  • [10] Radium-223 and metastatic castration-resistant prostate cancer: All that glitters is not gold
    Aprile, Carlo
    Persico, Marco G.
    Lodola, Lorenzo
    Buroni, Federica E.
    WORLD JOURNAL OF RADIOLOGY, 2016, 8 (10): : 816 - 818
12345